Skip to main content

Cisplatin News

Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer

FRIDAY, June 27, 2025 – For patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly...

Platinum Chemo Shortage Led to Reduced Use, No Change in Mortality

MONDAY, Dec. 30, 2024 – The platinum chemotherapy shortage, first announced on Feb. 10, 2023, resulted in a modest absolute reduction in platinum use, but no difference in mortality, according to a...

Last Year's Platinum-Based Drugs Shortage Didn't Raise Cancer Deaths, Study Found

TUESDAY, Dec. 24, 2024 – When supplies of certain generic, platinum-based cancer chemotherapies dwindled in 2023, oncologists feared it might lead to under-treatment and many more cancer deaths....

There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin

TUESDAY, Nov. 26, 2024 – Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate its side effects and quit the drug. A new trial...

2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer

TUESDAY, Oct. 1, 2024 – The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a...

Common Chemo Drug, Cisplatin, May Be Linked to Hearing Loss

MONDAY, July 1, 2024 (HealthDay news) – A 14-year study of testicular cancer survivors suggests that a chemotherapy drug could greatly raise patients' long-term odds for hearing loss. The drug in...

FDA Approves Merck’s Keytruda (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

RAHWAY, N.J.--(BUSINESS WIRE) November 1, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Non-Small Cell Lung Cancer, Ovarian Cancer

Cisplatin patient information at Drugs.com